Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mackenzie L Cottrell

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Analytical and Bioanalytical Chemistry|October 4, 2018
Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hairCraig Sykes, Kimberly Blake, Nicole White, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2022
Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study designCraig Sykes, Brian Van Horne, Justin Jones, et al.
Mbio|June 12, 2023
EFdA efficiently suppresses HIV replication in the male genital tract and prevents penile HIV acquisitionMartina Kovarova, Sarah E Wessel, Claire E Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)Arkaitz Imaz, Jordi Niubó, Mackenzie L Cottrell, et al.
AIDS (London, England)|December 30, 2025
Novel application of DBS tenofovir diphosphate to predict viral suppression in postpartum women living with HIV in MalawiRobert J Flick, Steven P Masiano, Tapiwa A Tembo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2021
Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormonesLinying Li, Gregory J Gatto, Rhonda M Brand, et al.
Pharmaceutics|May 27, 2023
Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming ImplantIsabella C Young, Allison L Thorson, Roopali Shrivastava, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
AIDS Research and Human Retroviruses|May 12, 2020
Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIVMelanie R Nicol, Mackenzie L Cottrell, Amanda H Corbett, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 29, 2018
A Pharmacokinetic/Pharmacodynamic Model to Predict Effective HIV Prophylaxis Dosing Strategies for People Who Inject DrugsKaty L Garrett, Jingxian Chen, Brian M Maas, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Analytical and Bioanalytical Chemistry|October 4, 2018
Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hairCraig Sykes, Kimberly Blake, Nicole White, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2022
Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study designCraig Sykes, Brian Van Horne, Justin Jones, et al.
Mbio|June 12, 2023
EFdA efficiently suppresses HIV replication in the male genital tract and prevents penile HIV acquisitionMartina Kovarova, Sarah E Wessel, Claire E Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)Arkaitz Imaz, Jordi Niubó, Mackenzie L Cottrell, et al.
AIDS (London, England)|December 30, 2025
Novel application of DBS tenofovir diphosphate to predict viral suppression in postpartum women living with HIV in MalawiRobert J Flick, Steven P Masiano, Tapiwa A Tembo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2021
Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormonesLinying Li, Gregory J Gatto, Rhonda M Brand, et al.
Pharmaceutics|May 27, 2023
Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming ImplantIsabella C Young, Allison L Thorson, Roopali Shrivastava, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
AIDS Research and Human Retroviruses|May 12, 2020
Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIVMelanie R Nicol, Mackenzie L Cottrell, Amanda H Corbett, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 29, 2018
A Pharmacokinetic/Pharmacodynamic Model to Predict Effective HIV Prophylaxis Dosing Strategies for People Who Inject DrugsKaty L Garrett, Jingxian Chen, Brian M Maas, et al.
Pageof 8